JESSY YOUNG: Open Payments
NPI 1194501908 · CORTE MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 41 payments from 12 companies in 2025. Trend: 2023 $57 · 2024 $703 · 2025 $1,168
Food & beverage: $1,069Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $360 |
| ABBVIE INC. | 10 | $211 |
| Madrigal Pharmaceuticals | 6 | $167 |
| Gilead Sciences, Inc. | 1 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| PFIZER INC. | 3 | $64 |
| QOL Medical, LLC | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Braintree Laboratories, Inc. | 1 | $25 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $25 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, Epclusa, RYBREVANT, ENTYVIO, LINZESS, XELJANZ.
Industry payments across CA — which companies pay providers there.
